Medical Patent News

RSS

Teva to market generic version of AstraZeneca's antipsychotic agent Seroquel tablets

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a July 1, 2008 decision by the District Court to grant AstraZeneca’s motion for summary judgment of no inequitable conduct related to U.S. Patent No. 4,879,288.

26 Sep 2009

Alcon's patent infringement suit against Synergetics USA stayed

Synergetics USA, Inc., a leading medical device company that designs, manufactures, and markets innovative microsurgical instruments and other devices, today announced that the lawsuit filed by Alcon Research, Ltd. against the Company in the Northern District of Texas, Case No. 4-08CV-609-Y has been stayed in its entirety until both of the patents at issue have completed re-examination in the United States Patent and Trademark Office (“PTO”).

25 Sep 2009

Oxygen Biotherapeutics submits a patent application for its heart attack treatment device

Oxygen Biotherapeutics, Inc. today announced that the company has submitted a patent application for a new invention that uses Oxycyte(R) perfluorocarbon to deliver oxygen as a first aid treatment for victims of heart attacks and strokes. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.

24 Sep 2009

Patents listed in FDA's Orange Book for Eli Lilly’s Evista invalidated

Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA’s Orange Book for Eli Lilly’s Evista® (raloxifene hydrochloride) Tablets in litigation concerning Teva’s abbreviated new drug application to market a generic version. The court found these patents to be invalid for lack of written description.

24 Sep 2009

Aerocrine announces the positive outcome of its complaint against Medisoft in Germany

Aerocrine AB today announced the positive outcome of its complaint against Medisoft P.A.E. filed at the District Court of Dusseldorf, Germany.

24 Sep 2009

Federal Court decides in favour of Cook and W. L. Gore & Associates in patent infringement case

Edwards Lifesciences Corporation,the global leader in the science of heart valves and hemodynamic monitoring, today announced the Court of Appeals for the Federal Circuit affirmed a previous court decision in favor of Cook Inc. and W. L. Gore & Associates, finding the companies did not infringe Edwards' patents for modular or multi-part endovascular grafts for treatment of abdominal aortic aneurysms (AAA).

24 Sep 2009

Court rules in favor of Eli Lilly for Evista's method-of-use patents

The U.S. District Court for the Southern District of Indiana today upheld Eli Lilly and Company's (NYSE: LLY) method-of-use patents on Evista(R) (raloxifene HCl tablets). In the case of Eli Lilly and Company v. Teva Pharmaceuticals Industries Ltd., the court ruled in favor of Lilly on all accounts for these method-of-use patents, including the patent doctrines of obviousness, enablement, and inequitable conduct.

24 Sep 2009

E-18 Corp. enters dental syringe market, completes US patent filing for the Protectus Safety Dental Syringe

E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company’s market opportunities to include the multi-billion dollar dental syringe market.

24 Sep 2009

NeuroTherm receives US patent for RF generator

NeuroTherm is pleased to be recognized by the United States Patent Office as the first company worldwide to develop and release a multiple output radiofrequency generator used in the treatment of chronic pain, ref. US Patent No. 7,574,257.

23 Sep 2009

Niti Surgical Solutions receives patent certificates for Hand CAC 30 and CAR 31 in Japan and China

NiTi Surgical Solutions, an innovative surgical device company, today announced the Japan Patent Office and the Patent Office of China have issued patent certificates that cover two of the company’s products, the Hand CAC™ 30 Compressions Anastomosis Clip applicator and CAR™ 31 Compression Anastomosis Ring.

23 Sep 2009

Advaxis' patent approval enables the development of new vaccines with additional properties

The United States Patent and Trademark Office (USPTO) has granted and issued Advaxis, Inc. (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, patent 7,588,930 “Compositions and Methods for Enhancing Immunogenicity of Antigens.” This patent expands the Company’s intellectual property portfolio to cover another family of adjuvant proteins based upon the Lm protein Act-A.

22 Sep 2009

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a new, smaller version of the CYPHER® Sirolimus-eluting Coronary Stent, the world’s most studied drug-eluting stent that has been used to treat nearly 4 million people worldwide. The new 2.25 mm CYPHER® Stent is indicated for treatment of coronary blockages in small vessels, an often difficult-to-treat situation.

22 Sep 2009

VeriChip granted exclusive license to virus triage detection system patents

VeriChip Corporation (“VeriChip”) (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip has been granted an exclusive license to RECEPTORS' Patent No. 7,504,364 titled “Methods of Making Arrays and Artificial Receptors” and Patent No. 7,469,076 “Sensors Employing Combinatorial Artificial Receptors,” in their application to the development of the virus triage detection system for the H1N1 virus.

21 Sep 2009

Perrigo purchases KV Pharmaceutical's ANDA for clindamycin phosphate and benzoyl peroxide gel

Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has purchased the ANDA for clindamycin phosphate (1%) and benzoyl peroxide (5%) gel from KV Pharmaceutical for $14 million in cash at closing and a $2 million milestone payment upon the completion of a successful technical transfer. This product is the AB-rated equivalent to Stiefel Laboratories' (a subsidiary of Glaxo SmithKline) Duac(R) gel, indicated for the topical treatment of inflammatory acne vulgaris.

21 Sep 2009

Impax Laboratories challenges Galderma Laboratories' patents

Impax Laboratories, Inc. confirms that it has initiated a challenge of the patents listed by Galderma Laboratories, L.P. in connection with its ORACEA® (doxycycline) delayed-release capsules, 40 mg.

21 Sep 2009

Cardinal Health patents disposable Nitrile gloves

Tillotson Corp. today announced that Cardinal Health has licensed a Tillotson U.S. patent for disposable Nitrile Gloves.

21 Sep 2009

Resolvyx Pharmaceuticals receives U.S. patent for RX-10045

Resolvyx Pharmaceuticals, Inc., the leading Resolvin therapeutics company, today announced that the U.S. Patent and Trademark Office has granted a patent (U.S. Patent 7,582,785) covering composition of matter for RX-10045, the first Resolvin therapeutic to enter clinical trials.

19 Sep 2009

JPO to grant patent from the Tuschl III patent series

Regulus Therapeutics Inc., Alnylam Pharmaceuticals, Inc., and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), announced today that the Japan Patent Office (JPO) has notified the Max Planck Society of its intent to grant a patent from the Tuschl III patent series (JP Application Number 2003-532675).

18 Sep 2009

Notice of Allowance issued by PTO for OSI's EGFR drug

OSI Pharmaceuticals, Inc. announced today that the U.S. Patent & Trademark Office has issued a “Notice of Allowance” in OSI’s reissue application for U.S. Patent No.5,747,498 (the ‘498) composition of matter patent for Tarceva® (erlotinib). The reissued patent will replace the original ‘498 patent and have the same November 2018 expiration date.

18 Sep 2009

New patent grant for oligonucleotide modulators of blood coagulation factor aptamers

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that the European Patent Office (EPO) has notified the Company of its intent to grant a patent with claims directed to oligonucleotide modulators of blood coagulation factor aptamers in EP 1401853. This new patent grant in the Company's portfolio extends the scope and breadth of Regado's intellectual property estate.

18 Sep 2009

Medical Patent News

Teva to market generic version of AstraZeneca's antipsychotic agent Seroquel tablets

Alcon's patent infringement suit against Synergetics USA stayed

Oxygen Biotherapeutics submits a patent application for its heart attack treatment device

Patents listed in FDA's Orange Book for Eli Lilly’s Evista invalidated

Aerocrine announces the positive outcome of its complaint against Medisoft in Germany

Federal Court decides in favour of Cook and W. L. Gore & Associates in patent infringement case

Court rules in favor of Eli Lilly for Evista's method-of-use patents

E-18 Corp. enters dental syringe market, completes US patent filing for the Protectus Safety Dental Syringe

NeuroTherm receives US patent for RF generator

Niti Surgical Solutions receives patent certificates for Hand CAC 30 and CAR 31 in Japan and China

Advaxis' patent approval enables the development of new vaccines with additional properties

FDA approves Cordis Corporation's 2.25 mm CYPHER Stent

VeriChip granted exclusive license to virus triage detection system patents

Perrigo purchases KV Pharmaceutical's ANDA for clindamycin phosphate and benzoyl peroxide gel

Impax Laboratories challenges Galderma Laboratories' patents

Cardinal Health patents disposable Nitrile gloves

Resolvyx Pharmaceuticals receives U.S. patent for RX-10045

JPO to grant patent from the Tuschl III patent series

Notice of Allowance issued by PTO for OSI's EGFR drug

New patent grant for oligonucleotide modulators of blood coagulation factor aptamers

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News